Short Interest in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) Expands By 124.5%

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 3,480,000 shares, a growth of 124.5% from the November 30th total of 1,550,000 shares. Currently, 9.5% of the company’s shares are short sold. Based on an average daily trading volume, of 6,750,000 shares, the days-to-cover ratio is presently 0.5 days.

Cardio Diagnostics Stock Performance

CDIO opened at $0.93 on Friday. Cardio Diagnostics has a 12 month low of $0.19 and a 12 month high of $3.56. The business has a 50-day moving average of $0.52 and a two-hundred day moving average of $0.45.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.